Video

Q&A With James List From Janssen Pharmaceuticals: Development Pipeline Gives Hopes to Future Kidney Disease Treatment Options

Author(s):

With two medications moving through the pipeline, patients with diabetic kidney disease may soon get a new treatment to prevent their developing end stage kidney disease.

%jwplayer%

With two medications moving through the pipeline, patients with diabetic kidney disease may soon get a new treatment to prevent their developing end stage kidney disease.

James List, MD, PhD, Global Therapeutic Area Head, Cardiovascular and Metabolism at Janssen Research and Development discussed these two new medications and what their potential approval could mean to patients in the future.

Related Videos
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
© 2024 MJH Life Sciences

All rights reserved.